---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-029612"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:47:17.257504+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TELA Bio launches larger OviTex PRS sizes for plastic/reconstructive surgery

## Summary
- Larger sizes include 25x30 cm oval and 25 cm diameter circle, the largest option on the market.
- OviTex PRS is the only reinforced polymer-suture tissue matrix for plastic/reconstructive surgery.
- Nearly 15,000 units sold since 2019; 31% YoY unit growth in 2024.
- New configurations aim to reduce need for multiple smaller pieces and simplify complex procedures.

## SEC filing metadata
- accession: 0001104659-25-029612
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465925029612/0001104659-25-029612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465925029612/tm2510876d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-029612
- JSON: https://secwatch.observer/filing/0001104659-25-029612.json
- Plain text: https://secwatch.observer/filing/0001104659-25-029612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.